| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.094 | 0.09 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |